The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
(1) Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S
Weiner ID, Mitch WE, Sands JM (2015) Urea and ammonia metabolism and the control of renal nitrogen excretion
You may not feel ALCAR unless youre elderly or an alcoholic
No, glutathione is not a fairness treatment. It works by improving skin health, reducing pigmentation, and enhancing natural radiance not by changing your natural skin tone
4.5 Investigational Agents in Clinical Trials A large number of investigational agents are currently in various phases of clinical trials for the treatment of ALS